BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33648461)

  • 1. ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
    Fonseca AS; Ramão A; Bürger MC; de Souza JES; Zanette DL; de Molfetta GA; de Araújo LF; de Barros E Lima Bueno R; Aguiar GM; Plaça JR; Alves CP; Dos Santos ARD; Vidal DO; Silva GEB; Panepucci RA; Peria FM; Feres O; da Rocha JJR; Zago MA; Silva WA
    BMC Cancer; 2021 Mar; 21(1):207. PubMed ID: 33648461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?
    Lin MT; Zheng G; Tseng LH; Zhang P; Ling H; Azad N; Gocke CD; Montgomery E; Eshleman JR
    Hum Pathol; 2020 Apr; 98():120-128. PubMed ID: 32171651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA AK027294 involves in the process of proliferation, migration, and apoptosis of colorectal cancer cells.
    Niu H; Hu Z; Liu H; Hu G; Yang B; Wu S; Li F
    Tumour Biol; 2016 Aug; 37(8):10097-105. PubMed ID: 26820130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIIP haploinsufficiency induces chromosomal instability and promotes tumour progression in colorectal cancer.
    Sun Y; Ji P; Chen T; Zhou X; Yang D; Guo Y; Liu Y; Hu L; Xia D; Liu Y; Multani AS; Shmulevich I; Kucherlapati R; Kopetz S; Sood AK; Hamilton SR; Sun B; Zhang W
    J Pathol; 2017 Jan; 241(1):67-79. PubMed ID: 27741356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
    Arvai KJ; Hsu YH; Lee LA; Jones D
    PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
    Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
    Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
    World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sp1 upregulates expression of TRF2 and TRF2 inhibition reduces tumorigenesis in human colorectal carcinoma cells.
    Dong W; Shen R; Wang Q; Gao Y; Qi X; Jiang H; Yao J; Lin X; Wu Y; Wang L
    Cancer Biol Ther; 2009 Nov; 8(22):2166-74. PubMed ID: 19783902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness.
    Toiyama Y; Inoue Y; Yasuda H; Saigusa S; Yokoe T; Okugawa Y; Tanaka K; Miki C; Kusunoki M
    J Gastroenterol; 2011 Feb; 46(2):153-63. PubMed ID: 20824289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer.
    Luo Y; Wong CJ; Kaz AM; Dzieciatkowski S; Carter KT; Morris SM; Wang J; Willis JE; Makar KW; Ulrich CM; Lutterbaugh JD; Shrubsole MJ; Zheng W; Markowitz SD; Grady WM
    Gastroenterology; 2014 Aug; 147(2):418-29.e8. PubMed ID: 24793120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRSS8 suppresses colorectal carcinogenesis and metastasis.
    Bao Y; Guo Y; Yang Y; Wei X; Zhang S; Zhang Y; Li K; Yuan M; Guo D; Macias V; Zhu X; Zhang W; Yang W
    Oncogene; 2019 Jan; 38(4):497-517. PubMed ID: 30115975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
    Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
    Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRAS-mediated up-regulation of RRM2 expression is essential for the proliferation of colorectal cancer cell lines.
    Yoshida Y; Tsunoda T; Doi K; Tanaka Y; Fujimoto T; Machida T; Ota T; Koyanagi M; Takashima Y; Sasazuki T; Kuroki M; Iwasaki A; Shirasawa S
    Anticancer Res; 2011 Jul; 31(7):2535-9. PubMed ID: 21873171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.
    Ma SS; Srivastava S; Llamosas E; Hawkins NJ; Hesson LB; Ward RL; Ford CE
    BMC Cancer; 2016 Jul; 16():508. PubMed ID: 27440078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-surface markers for colon adenoma and adenocarcinoma.
    Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
    Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.